Sign Up Today and Learn More About Seven Bridges Stock
Invest in or calculate the value of your shares in Seven Bridges or other pre-IPO companies through EquityZen's platform.
About Seven Bridges Stock
Founded
2009
Headquarters
Charlestown, MA, US
Total Funding
98.0M
Industries
Software, Artificial Intelligence, Data and Analytics
Seven Bridges is the industry-leading infrastructure and data analytics company accelerating precision medicine by enabling the understanding of biomedical data. Our platform, services, and support expertise are driving discovery and drug development at the world’s leading academic, biotechnology, government, hospitals, and pharmaceutical entities. Through our collaborations with the largest genomics projects, we connect the world’s biomedical information to enable the most efficient analysis at scale. Named one of the world's smartest companies by MIT Technology Review, and a three-time Bio-IT World Best of Show winner, Seven Bridges has offices in Belgrade, Boston, Istanbul, and San Francisco.
Seven Bridges Press Mentions
Stay in the know about the latest news on Seven Bridges
Velsera Makes NVIDIA Parabricks Tools Available for Global Researchers on the Seven Bridges Platform
businesswire • Nov 02, 2023
Velsera to Showcase Seven Bridges Bioinformatics Platform at BioTechX Europe
businesswire • Oct 04, 2023
New Company, Velsera, Represents Summa Equity's Vision to Improve Global Health Outcomes
businesswire • Jan 24, 2023
Pierian, Seven Bridges, UgenTec Acquired, Merged to Become Velsera
genomeweb • Jan 14, 2023
Seven Bridges, Google Cloud Partner on Brazilian Reference Genome Project
genomeweb • Apr 20, 2022
Investors in Seven Bridges
Discover investors in Seven Bridges stock and explore their portfolio companies
Seven Bridges Management
Leadership team at Seven Bridges
Chief Executive Officer
William Moss
Chief Financial Officer
Robert Shay
Join now and verify your accreditation status to gain access to:
- Seven Bridges current valuation
- Seven Bridges stock price
- Available deals in Seven Bridges and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Seven Bridges Stock
How to invest in Seven Bridges stock?
Accredited investors can buy pre-IPO stock in companies like Seven Bridges through EquityZen funds. These investments are made available by existing Seven Bridges shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Seven Bridges stock?
Shareholders can sell their Seven Bridges stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
